Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 25 points (-0.1%) at 18,080 as of Tuesday, May 12, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,119 issues advancing vs. 1,860 declining with 154 unchanged. The Health Services industry currently sits down 0.6% versus the S&P 500, which is down 0.3%. Top gainers within the industry include Edwards Lifesciences ( EW), up 3.4%, and Opko Health ( OPK), up 3.1%. On the negative front, top decliners within the industry include Foundation Medicine ( FMI), down 9.6%, Mindray Medical International ( MR), down 4.7%, Community Health Systems ( CYH), down 2.4%, Universal Health Services ( UHS), down 2.2% and HCA Holdings ( HCA), down 1.4%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Cigna ( CI) is one of the companies pushing the Health Services industry higher today. As of noon trading, Cigna is up $3.05 (2.4%) to $131.35 on heavy volume. Thus far, 2.6 million shares of Cigna exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $127.68-$132.74 after having opened the day at $127.68 as compared to the previous trading day's close of $128.30. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $33.1 billion and is part of the health care sector. Shares are up 24.9% year-to-date as of the close of trading on Monday. Currently there are 8 analysts who rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold. TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and growth in earnings per share. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Cigna Ratings Report now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.